Director, Commercial Strategy & Operations Lead

Overview

This role works very closely with the SVP, Head of Int’l BU, and reports to the VP, Head of Commercial. The Commercial Strategy and Operations Lead has a broad responsibility for strategic planning and operational coordination of International BU leadership. S/he will serve as the primary “owner” of governance processes (dashboard, agendas, attendance, meetings) and strategic initiatives to accomplish our 5 years vision and beyond. S/he will cultivate operational excellence within the International BU. This individual serves as a key member of the BU leadership team and will actively contribute to the BU strategic vision, decision-making and execution as well as embody the values envisaged of company senior leaders.

In practice, this includes:

1. The definition and progress tracking of the yearly International BU Leadership Team Strategic Priorities and Milestones
2. The organization and coordination of BU Leadership Team meetings to ensure proper governance of the Business Unit and coverage of all relevant strategic and operational topics in this forum.
3. The preparation and coordination of the annual country and functional Deep Dive Reviews
4. The preparation and coordination of performance reviews
   1. Monthly Operating Review
   2. Monthly & Quarterly Business Reviews to Alnylam Senior Management
   3. Ad-hoc business reviews
   4. The International TTR Commercial Strategy and Operations Lead will collaborate with the global analytics functions to ensure the design and maintenance of international’s performance dashboards along with reporting on core KPIs. S/he should continue improving dashboards and key processes to foster a culture of accountability and "operational excellence" across functions.
5. Strategic projects to increase organizational and operational effectiveness

This role is suited to candidates who have deep relevant experience with a pharmaceutical company or consultancy, ideally with an experience on rare diseases. Strong candidates will have the ability to view the bigger picture while also being able to analyze detail, and showcase exceptional communication and presentation skills. It is a highly visible role which will give the candidate the opportunity to develop a deep understanding of Alnylam’s TTR business in International and to shape its future development.

The position will preferably be located in Zug, Switzerland.

Key Responsibilities

• Lead and oversee International BU leadership meetings (agendas, materials, action items, pre-read)
• Develop key strategic presentation for the SVP Head of International, including performance reviews, board decks
• Lead ad hoc strategic projects for the BU
• In partnership with communication, support SVP Head of International’s communication plan for related forums (Town Hall, POAs, others)
• Coordinate and facilitate regular performance reviews and update within the BU (MOR, MBR, and QBR)
• Coordinate annual planning and ongoing goal and resource tracking within the BU
• Drive formation and tracking of International BU goals
• In collaboration with finance and commercial expertise areas, co-ordinate planning activities
• Liaise cross-functionally (Legal, Compliance Finance, Procurement, HR, Regulatory, Global and other functions as necessary) to support efficient and timely execution of International commercial objectives
• Independently identify and resolve issues limiting execution with focus on simplification
• Responsible for identifying, recommending, and executing process improvement initiatives. Modify processes to meet the evolving needs of the business
• Collaborate with meeting owners of other key governance bodies to ensure potential duplication of effort/discussion is avoided and ensure the right discussions occur at the appropriate forums
• Prepare read out communications materials, designed to keep interested parties appraised and informed of the meeting while containing meeting size
• Maintain contemporary knowledge of Alnylam’s business activities, alliances, RNAi science, relevant diseases and therapeutic areas
• Participate in commercial team meetings to understand business needs and contribute to performance and planning discussions
• Ensure that deliverables required by the global headquarters and other regional leaders are provided punctually and to a high-level of quality

Qualifications

• MSc degree in scientific discipline (ideally) and/or business
• 10 years of professional experience, with at least 5 years of experience in the biotechnology or pharmaceutical industry.
• Strong story-telling skills and ability to build clear and impactful strategic slides.
• Strong budget, analytical, problem-solving, organization and communication skills.
• A highly driven, engaged and accomplished operational leader who demonstrates passion and a sense of urgency
• Excellent problem solving and execution skills, capable to handle many conflicting priorities with a high degree of autonomy
• Ability to build strong working relationships cross-functionally and across levels, excellent stakeholder engagement skills
• Comfortable with interacting with senior internal and external stakeholders
• Ability to influence without authority
• Strong written and oral communication skills
• Proficient in ppt and xls
• Sound judgment and discretion in sensitive matters
• Thrives in highly entrepreneurial biotech environment and embraces Alnylam’s culture of science, passion and urgency
• Intellectual curiosity, adaptability, and desire to learn and grow to meet the evolving needs of the organization
• Ability to travel internationally as required by the business

About Alnylam

• Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. 
• Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in France, Italy, Spain, Switzerland, and UK – among others.
• At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.